Status:
COMPLETED
Study of Physiological Signals During and After COPD Exacerbations
Lead Sponsor:
Biosency
Collaborating Sponsors:
Slb Pharma
Air de Bretagne
Conditions:
COPD
COPD Exacerbation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background : Acute exacerbations of COPD (Chronic Obstructive Pulmonary Disease) are frequent events in the course of the disease and they can deteriorate the respiratory function of the patients, imp...
Eligibility Criteria
Inclusion
- patient known or suspected to suffer from COPD
- patient admitted in pulmonology unit for COPD exacerbation
- patient accepting to use BORA Band during and after hospitalization
- patient accepting to be followed by the partner health care provider for this study (Air de Bretagne)
- patient able to understand French and express their informed consent
- patient affiliated to social security
Exclusion
- patient is intubated
- patient already followed by a health care provider other than Air de Bretagne
- investigator assesses that the patient will have difficulties following the protocol
- patient already enrolled in another interventional study
Key Trial Info
Start Date :
February 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 6 2024
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04034901
Start Date
February 19 2021
End Date
February 6 2024
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chru Pontchaillou
Rennes, France, 35000